Mid-size CRO consolidation: Chiltern completes Theorem deal

By Dan Stanton contact

- Last updated on GMT

Mid-size consolidation: Chiltern completes Theorem merger
Mid-size consolidation: Chiltern completes Theorem merger

Related tags: Contract research organization

Chiltern has completed its acquisition of Theorem, making it the self-declared “largest mid-sized” CRO.

A month after the announcement was made, mid-sized contract research organisation (CRO) Chiltern has finalised its acquisition of fellow mid-size player, creating a clinical trial services firm comprising of 3,700 people across 47 countries.

“We have created a unique, mid-sized research partner focused on providing exceptional scientific expertise and personal service,”​ Chiltern CEO Jim Esinhart said. “Clients can expect the same high level of service, now with expanded capabilities.”

Chiltern Chairman Nick Thornton added: “We stayed true to our mission to be a responsive, client-centric mid-sized provider, yet we enhanced our geographic coverage and service offerings in key areas.”

Through the deal, the company expands its Oncology, Biopharma and Source offerings, and established new capabilities in medical device and diagnostics, clinical analytics and clinical supplies.

While the CRO industry is dominated by the top eight players​ – Quintiles, Covance, PRA, Parexel, PPD, Icon, INC and inVentiv – Chiltern can offer comprehensive, yet flexible and responsive, clinical development services, the company says, while Senior leadership can continue to be involved in running trials.

Fellow mid-sized player SynteractHCR recently shared a similar opinion to Outsourcing-Pharma.com​, suggesting customers like working with a mid-sized CRO as it retains personal attention but across a global network.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us

Products

View more

Webinars